These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21627609)

  • 1. [Prognostic value of various markers of inflammation in ST-elevation myocardial infarction].
    Barbarash OL; Zykov MV; Kashtalap VV; Osokina AV; Berns SA; Karetnikova VN
    Kardiologiia; 2011; 51(3):24-30. PubMed ID: 21627609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome.
    Kaski JC; Consuegra-Sanchez L; Fernandez-Berges DJ; Cruz-Fernandez JM; Garcia-Moll X; Marrugat J; Mostaza J; Toro-Cebada R; González-Juanatey JR; Guzmán-Martínez G;
    Atherosclerosis; 2008 Nov; 201(1):176-83. PubMed ID: 18336825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stress.
    Tomandlova M; Jarkovsky J; Tomandl J; Kubkova L; Kala P; Littnerova S; Gottwaldova J; Kubena P; Ganovska E; Poloczek M; Spinar J; Mueller C; Mebazaa A; Pavkova Goldbergova M; Parenica J
    Dis Markers; 2015; 2015():159051. PubMed ID: 25922551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neopterin, nitric oxide, inducible nitric oxide synthase and tumor necrosis factor-alpha levels in patients with ischemic heart disease.
    Djordjevic VB; Stojanovic I; Cosic V; Zvezdanovic L; Deljanin-Ilic M; Dimic S; Kundalic B; Cvetkovic T; Jevtovic-Stoimenov T
    Clin Chem Lab Med; 2008; 46(8):1149-55. PubMed ID: 18605955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease.
    Avanzas P; Arroyo-Espliguero R; Cosin-Sales J; Quiles J; Zouridakis E; Kaski JC
    Am J Cardiol; 2004 Mar; 93(5):627-9. PubMed ID: 14996595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prediction of adverse cardiac events in patients with acute anterior wall myocardial infarction treated with PCI].
    Wita K; Filipecki A; Szczogiel J; Drzewiecka-Gerber A; Rybicka A; Krauze J; Wróbel W; Szydło K; Urbańczyk D; Turski M; Tabor Z; Kwaśniewski W; Mróz I; Trusz-Gluza M
    Pol Arch Med Wewn; 2006 Jul; 116(1):648-57. PubMed ID: 17340971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
    Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
    Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of subclinical inflammation in progression of multifocal atherosclerosis during one year after myocardial infarction].
    Barbarash OL; Usol'tseva EN; Kashtalap VV; Kolomytseva IS; Sizova IN; Volykova MA; Shibanova IA
    Kardiologiia; 2014; 54(8):19-25. PubMed ID: 25464606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic usefulness of serial C-reactive protein measurements in ST-elevation acute myocardial infarction.
    Makrygiannis SS; Ampartzidou OS; Zairis MN; Patsourakos NG; Pitsavos C; Tousoulis D; Prekates AA; Foussas SG; Cokkinos DV
    Am J Cardiol; 2013 Jan; 111(1):26-30. PubMed ID: 23040593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predischarge QRS score and risk for heart failure after first ST-elevation myocardial infarction.
    Kalogeropoulos AP; Chiladakis JA; Sihlimiris I; Koutsogiannis N; Alexopoulos D
    J Card Fail; 2008 Apr; 14(3):225-31. PubMed ID: 18381186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions?
    Locca D; Bucciarelli-Ducci C; Ferrante G; La Manna A; Keenan NG; Grasso A; Barlis P; Del Furia F; Prasad SK; Kaski JC; Pennell DJ; Di Mario C
    JACC Cardiovasc Interv; 2010 Sep; 3(9):950-8. PubMed ID: 20850095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.
    Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M
    Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden?
    Gotsman I; Stabholz A; Planer D; Pugatsch T; Lapidus L; Novikov Y; Masrawa S; Soskolne A; Lotan C
    Isr Med Assoc J; 2008 Jul; 10(7):494-8. PubMed ID: 18751625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated circulating IL-32 presents a poor prognostic outcome in patients with heart failure after myocardial infarction.
    Xuan W; Huang W; Wang R; Chen C; Chen Y; Wang Y; Tan X
    Int J Cardiol; 2017 Sep; 243():367-373. PubMed ID: 28747035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction.
    Maas AC; Wyatt CM; Green CL; Wagner GS; Trollinger KM; Pope JE; Langer A; Armstrong PW; Califf RM; Simoons ML; Krucoff MW
    Am Heart J; 2004 Apr; 147(4):698-704. PubMed ID: 15077087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of tumor necrosis factor-alpha in patients with ST-segment elevation acute myocardial infarction].
    Gonzálvez M; Ruiz-Ros JA; Pérez-Paredes M; Lozano ML; García-Almagro FJ; Martínez-Corbalán F; Giménez DM; Carrillo A; Carnero A; Cubero T; Gonzálvez JJ; Ureña I; Vicente V
    Rev Esp Cardiol; 2007 Dec; 60(12):1233-41. PubMed ID: 18082088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
    Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
    J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.